Literature DB >> 7189404

Suppressive factor of tumour origin against macrophage phagocytosis of Staphylococcus aureus.

H Saito, H Tomioka.   

Abstract

Peritoneal macrophages from Sarcoma-180-bearing mice against Staphylococcus aureus were studied to determine the in vitro phagocytic capacities. When the phagocytic system was opsonized with normal mouse serum, macrophage phagocytic activity increased markedly soon after tumour graft and then returned to normal. A new antiphagocytic factor was detected in the serum of tumour-bearers soon after tumour implantation. This factor was of tumour origin, stable even at a temperature of 56 degrees C for 30 min and non-dialysable. Peptone-starch-induced macrophages were less sensitive to the factor than their unstimulated counterpart.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7189404      PMCID： PMC2010204          DOI： 10.1038/bjc.1980.38

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  8 in total

1.  Macrophage function in tumor-bearing mice: dissociation of phagocytic and chemotactic responsiveness.

Authors:  M S Meltzer; M M Stevenson
Journal:  Cell Immunol       Date:  1978-01       Impact factor: 4.868

2.  Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection.

Authors:  R J North; D P Kirstein; R L Tuttle
Journal:  J Exp Med       Date:  1976-03-01       Impact factor: 14.307

3.  Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance.

Authors:  M C Pike; R Snyderman
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

4.  Alterations of mononuclear phagocyte function induced by Lewis lung carcinoma in C57BL mice.

Authors:  A A Otu; R J Russell; P C Wilkinson; R G White
Journal:  Br J Cancer       Date:  1977-09       Impact factor: 7.640

5.  Subversion of host defense mechanisms by murine tumors. II. Counter-influence of concomitant antitumor immunity.

Authors:  R J North; D P Kirstein; R L Tuttle
Journal:  J Exp Med       Date:  1976-03-01       Impact factor: 14.307

6.  T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites.

Authors:  R J North; D P Kirstein
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

7.  Interactions between rabbit polymorphonuclear leucocytes and staphylococci.

Authors:  Z A COHN; S I MORSE
Journal:  J Exp Med       Date:  1959-09-01       Impact factor: 14.307

8.  Inhibition of phagocytosis and glucose metabolism of alveolar macrophages during pulmonary tumour growth.

Authors:  P W Gudewicz; T M Saba
Journal:  Br J Cancer       Date:  1977-12       Impact factor: 7.640
  8 in total
  4 in total

1.  Inhibition of normal rat macrophage functions by soluble tumor products. Effect of systemic treatment with bacterial immunomodulators.

Authors:  D Iannello; L Bonina; D Delfino; M C Berlinghieri; P Mastroeni
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

2.  Increased translocation of bacteria from the gastrointestinal tracts of tumor-bearing mice.

Authors:  R L Penn; R D Maca; R D Berg
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

3.  The effect of intravenous Corynebacterium parvum on gut associated mononuclear phagocytes in normal and tumour bearing rats.

Authors:  R G Souter; H W Steer
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

4.  Inhibition by the Landschütz ascites carcinoma of the granulomatous inflammatory response to C. parvum.

Authors:  L C McIntosh; R G Pugh-Humphreys; R A Fraser; A W Thomson
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.